SIA Partners
Latham BioPharm Group (LBG) provides expert consulting services across a wide range of life sciences, including vaccine development, therapeutics, cell & gene therapies, medical devices, diagnostics, and digital health. They support clients with funding, product development, strategic consulting, and industry expertise to help reach organizational objectives. Recently, LBG became part of Sia Partners, expanding their capabilities and reach.
Industries
Nr. of Employees
medium (51-250)
SIA Partners
Maynard, Massachusetts, United States, North America
Products
Non-dilutive Funding
Assistance in securing funding from government agencies and opportunities without diluting company ownership.
Product Development
Support across all stages of product development for vaccines, therapeutics, cell and gene therapies, and medical devices.
Strategic Consulting
Consulting services including pipeline and portfolio analysis, market research, and financial modeling.
Government Relations
Facilitation of interactions with government entities to support product development and funding.
Proposal Development
Assistance in creating proposals for securing funding and project support.
Post-award Support
Support services following the award of funding, ensuring compliance and project success.
Non-dilutive Funding
Assistance in securing funding from government agencies and opportunities without diluting company ownership.
Product Development
Support across all stages of product development for vaccines, therapeutics, cell and gene therapies, and medical devices.
Strategic Consulting
Consulting services including pipeline and portfolio analysis, market research, and financial modeling.
Government Relations
Facilitation of interactions with government entities to support product development and funding.
Proposal Development
Assistance in creating proposals for securing funding and project support.
Post-award Support
Support services following the award of funding, ensuring compliance and project success.
Services
Non-dilutive funding advisory
Consulting to identify government funding opportunities, develop proposals, and provide post-award support including contract compliance.
Product development consulting
End-to-end product development support including CMC, regulatory strategy, clinical development, nonclinical studies, discovery, quality systems, project and vendor management.
Strategic consulting
Services including strategic planning, financial modeling, market research, supply chain optimization, market access and due diligence.
Non-dilutive funding advisory
Consulting to identify government funding opportunities, develop proposals, and provide post-award support including contract compliance.
Product development consulting
End-to-end product development support including CMC, regulatory strategy, clinical development, nonclinical studies, discovery, quality systems, project and vendor management.
Strategic consulting
Services including strategic planning, financial modeling, market research, supply chain optimization, market access and due diligence.
Expertise Areas
- Cell and gene therapy development
- Vaccine development
- Therapeutic product development
- Bioprocessing and biomanufacturing
Key Technologies
- Viral vector manufacturing
- Autologous cell therapy (CAR-T) manufacturing
- Point-of-care diagnostic platforms
- AI-enabled diagnostics and decision support